BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• Business

  Genus And Caribou Biosciences Announce Exclusive Collaboration For Leading CRISPR-Cas9 Gene Editing Technology In Livestock Species

  May 18, 2016

   · 

  5 min read
• BioCapital

  Xeltis Release: Pediatric Feasibility Study Results Set Stage For Clinical Trial Of World’s First Bioabsorbable Heart Valve Enabling Endogenous Tissue Restoration

  May 18, 2016

   · 

  3 min read
• Genetown

  InspireMD Ltd.'s CGuard Highlighted At The Late-Breaking Clinical Trial Session At The EuroPCR 2016 Conference

  May 18, 2016

   · 

  6 min read
• Business

  NFANT Labs Expanding Connected Neonatal Product Line With Upcoming Series B Offering

  May 18, 2016

   · 

  2 min read
• Pharm Country

  CDx Diagnostics To Unveil New Data Demonstrating A Significant Advance In The Prevention Of The Most Rapidly Growing Cancer In The U.S.

  May 18, 2016

   · 

  3 min read
• FDA

  Bristol-Myers Squibb Release: Opdivo (nivolumab) Granted First Approval Of A PD-1 Inhibitor In Hematology For The Treatment Of Classical Hodgkin Lymphoma Patients Who Have Relapsed Or Progressed After Auto-HSCT And Post-Transplantation Brentuximab Vedotin

  May 18, 2016

   · 

  6 min read
• Business

  Emerald Medical Applications Corp (OTCQB: MRLA) Appoints Pharmaceutical Industry Expert Dr. Ben-Zion Weiner To Its Scientific Advisory Board

  May 18, 2016

   · 

  4 min read
• Genetown

  SOLA Biosciences Announces New Website Launch

  May 18, 2016

   · 

  1 min read
• Business

  Viramal Limited Appoints Experienced Pharmaceutical Executive, Angela Rossetti, To Board Of Directors

  May 18, 2016

   · 

  1 min read
• Drug Development

  Synthon Advances Clinical Evaluation Of Anti-HER2 ADC SYD985 In An Expanded Cohort Of HER2-Positive Metastatic Breast Cancer Patients

  May 18, 2016

   · 

  6 min read